China Resources Pharmaceutical (03320): Net profit attributable to the mid-term shareholders of China Resources Jiangzhong was 491 million yuan, a decrease of 5.92% year-on-year

According to the Zhitong Finance App, China Resources Pharmaceutical (03320) announced China Resources Jiangzhong's results for the six months ended June 30, 2026, with total operating income of RMB 1,932 billion, a decrease of 9.75%; net profit attributable to shareholders of listed companies was RMB 491 million, a decrease of 5.92% year on year; and basic profit per share was 0.78 yuan.